Finance

Beta
Lists
GLAPY:OTCMKTS
Glanbia plc
$131.01
+3.16%
(+4.01) 1D
Jun 3, 9:48:11 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLAPY...
Open
$131.01
High
$131.01
Low
$131.01
Mkt. cap
5.05B
Avg. vol.
70.00
Volume
273.00
52-wk high
$131.01
52-wk low
$79.41
Beta
0.56
Shares outstanding
48.41M
No. of employees
5K
Open
$131.01
High
$131.01
Low
$131.01
Mkt. cap
5.05B
Avg. vol.
70.00
Volume
273.00
52-wk high
$131.01
52-wk low
$79.41
Beta
0.56
Shares outstanding
48.41M
No. of employees
5K
News stories
From sources across the web
Profile
Glanbia plc is an Irish multinational nutrition company that owns several consumer brands that produce products such as food supplements and ingredients businesses. Glanbia is headquartered in Kilkenny, Ireland with over 5,500 employees in over 30 countries around the world. Glanbia’s consumer brands and ingredients are sold or distributed in over 130 countries. North America is the company’s largest market, and it also has a presence in Europe, Middle East, Asia-Pacific and Latin America. Glanbia's primary listing is on Euronext Dublin. Glanbia comprises three divisions: Glanbia Nutritionals, Glanbia Performance Nutrition and Joint Ventures. Given the company's origins in the co-operative movement, farmer-suppliers of the company retain a significant interest in the company. Tirlán remains the largest shareholder in Glanbia plc. as of 2022 and retains the right to nominate a number of non-executive directors to the board of the company in line with their mutual Relationship Agreement. Wikipedia
About Glanbia plc
CEOHugh McGuire
Employees4.96K
Founded1997
Headquarters-
SectorFood
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
963.35M
963.35M
1.01B
1.01B
Cost of goods sold
700.30M
700.30M
742.10M
742.10M
Cost of revenue
700.30M
700.30M
742.10M
742.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
162.20M
162.20M
155.35M
155.35M
Operating expense
180.60M
180.60M
175.05M
175.05M
Total operating expenses
880.90M
880.90M
917.15M
917.15M
Operating income
82.45M
82.45M
92.70M
92.70M
Other non operating income
-750.00K
-750.00K
-550.00K
-550.00K
EBT including unusual items
57.25M
57.25M
47.35M
47.35M
EBT excluding unusual items
77.35M
77.35M
88.65M
88.65M
Income tax expense
7.55M
7.55M
5.40M
5.40M
Effective tax rate
13.19%
13.19%
11.40%
11.40%
Other operating expenses
-900.00K
-900.00K
1.35M
1.35M
Net income
49.70M
49.70M
41.95M
41.95M
Net profit margin
5.16%
5.16%
4.15%
4.15%
Earnings per share
-
-
-
-
Interest and investment income
550.00K
550.00K
650.00K
650.00K
Interest expense
-6.60M
-6.60M
-8.00M
-8.00M
Net interest expenses
-6.05M
-6.05M
-7.35M
-7.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
115.05M
115.05M
110.95M
110.95M
Gain or loss from assets sale
4.35M
4.35M
18.70M
18.70M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more